TrialMedical oncology (Northwood, London, England)2014

Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.

Yao-Kuang Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.